They are complementary rather than competing, with BPC-157 addressing structural repair and LL-37 addressing infection defense and innate immune signaling during wound healing
By acting as a hepatocyte growth factor (HGF)/c-Met agonist, it promotes neuroplasticity, memory formation, and potential repair of damaged neural circuits
Pure dividend-focused approach The teams fundamental research focuses on ensuring each companys dividend is dynamic, durable, and decisive
That matters clinically because tendon and ligament recovery depends heavily on cellular repair activity, collagen organization, vascular support, and the ability to gradually reload tissue
Additionally, BPC 157 has shown promise in ameliorating neurological deficits after strokes in animal models, indicating a potential area for human clinical trials
Homeostatic Control: Because this works on a regulatory level, BPC-157 is modulatory